Environmental immunology: Lessons learned from exposure to a select panel of immunotoxicants

Journal of Immunology

Volumn 196, Issue 8, 2016, Pages 3217-3225

  Kreitinger, Joanna M ^a   Beamer, Celine A ^a   Shepherd, David M ^a  

^a UNIVERSITY OF MONTANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; IMMUNOTOXIN; NANOMATERIAL; XENOBIOTIC AGENT; 4,4' ISOPROPYLIDENEDIPHENOL; BENZHYDRYL DERIVATIVE; PHENOL DERIVATIVE; POLLUTANT; POLYCHLORINATED BIPHENYL; POLYCHLORINATED DIBENZODIOXIN;

CONTAMINATION; DEVELOPMENT; ENVIRONMENT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMMUNOLOGY; HUMAN; IMMUNE SYSTEM; IMMUNE SYSTEM DEVELOPMENT; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; ADVERSE EFFECTS; ANIMAL; DRUG EFFECTS; EMBRYOLOGY; INNATE IMMUNITY; POLLUTANT; RAT; TOXICITY;

ANIMALS; BENZHYDRYL COMPOUNDS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; NANOSTRUCTURES; PHENOLS; POLYCHLORINATED BIPHENYLS; POLYCHLORINATED DIBENZODIOXINS; RATS; RECEPTORS, ARYL HYDROCARBON; XENOBIOTICS;

EID: 84974855906     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502149     Document Type: Review

References (116)

1. Nebert, D. W., and L. L. Bausserman. 1970. Genetic differences in the extent of aryl hydrocarbon hydroxylase induction in mouse fetal cell cultures. J. Biol. Chem. 245: 6373-6382.
2. Okey, A. B. 2007. An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann Lecture, International Congress of Toxicology-XI. Toxicol. Sci. 98: 5-38.
3. Poland, A., E. Glover, and A. S. Kende. 1976. Stereospecific, high affinity binding of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J. Biol. Chem. 251: 4936-4946.
4. Kouri, R. R., H. Ratrie, III, S. A. Atlas, A. Niwa, and D. W. Nebert. 1974. Aryl hydrocarbon hydroxylase induction in human lymphocyte cultures by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Life Sci. 15: 1585-1595.
5. Gasiewicz, T. A., W. C. Ness, and G. Rucci. 1984. Ontogeny of the cytosolic receptor for 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in rat liver, lung, and thymus. Biochem. Biophys. Res. Commun. 118: 183-190.
6. Silkworth, J. B., and L. Antrim. 1985. Relationship between Ah receptor-mediated polychlorinated biphenyl (PCB)-induced humoral immunosuppression and thymic atrophy. J. Pharmacol. Exp. Ther. 235: 606-611.
7. Silkworth, J. B., L. Antrim, and L. S. Kaminsky. 1984. Correlations between polychlorinated biphenyl immunotoxicity, the aromatic hydrocarbon locus, and liver microsomal enzyme induction in C57BL/6 and DBA/2 mice. Toxicol. Appl. Pharmacol. 75: 156-165.
8. Silkworth, J. B., L. A. Antrim, and G. Sack. 1986. Ah receptor mediated suppression of the antibody response in mice is primarily dependent on the Ah phenotype of lymphoid tissue. Toxicol. Appl. Pharmacol. 86: 380-390.
9. Nikolaidis, E., B. Brunström, and L. Dencker. 1988. Effects of the TCDD congeners 3, 39, 4, 49-tetrachlorobiphenyl and 3, 39, 4, 49-tetrachloroazoxybenzene on lymphoid development in the bursa of Fabricius of the chick embryo. Toxicol. Appl. Pharmacol. 92: 315-323.
10. Stockinger, B., P. Di Meglio, M. Gialitakis, and J. H. Duarte. 2014. The aryl hydrocarbon receptor: multitasking in the immune system. Annu. Rev. Immunol. 32: 403-432.
11. Esser, C., and A. Rannug. 2015. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. Pharmacol. Rev. 67: 259-279.
12. Frericks, M., M. Meissner, and C. Esser. 2007. Microarray analysis of the AHR system: tissue-specific flexibility in signal and target genes. Toxicol. Appl. Pharmacol. 220: 320-332.
13. Kerkvliet, N. I. 2009. AHR-mediated immunomodulation: the role of altered gene transcription. Biochem. Pharmacol. 77: 746-760.
14. Hanieh, H. 2014. Toward understanding the role of aryl hydrocarbon receptor in the immune system: current progress and future trends. BioMed Res. Int. 2014: 520763.
15. Wheeler, T. A., K. S. Lawrence, D. O. Porter, W. Keeling, and B. G. Mullinix, Jr. 2013. The relationship between environmental variables and response of cotton to nematicides. J. Nematol. 45: 8-16.
16. Stockinger, B., K. Hirota, J. Duarte, and M. Veldhoen. 2011. External influences on the immune system via activation of the aryl hydrocarbon receptor. Semin. Immunol. 23: 99-105.
17. Benson, J. M., and D. M. Shepherd. 2011. Dietary ligands of the aryl hydrocarbon receptor induce anti-inflammatory and immunoregulatory effects on murine dendritic cells. Toxicol. Sci. 124: 327-338.
18. Bankoti, J., B. Rase, T. Simones, and D. M. Shepherd. 2010. Functional and phenotypic effects of AhR activation in inflammatory dendritic cells. Toxicol. Appl. Pharmacol. 246: 18-28.
19. Marshall, N. B., W. R. Vorachek, L. B. Steppan, D. V. Mourich, and N. I. Kerkvliet. 2008. Functional characterization and gene expression analysis of CD4+ CD25+ regulatory T cells generated in mice treated with 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. J. Immunol. 181: 2382-2391.
20. Quintana, F. J., G. Murugaiyan, M. F. Farez, M. Mitsdoerffer, A. M. Tukpah, E. J. Burns, and H. L. Weiner. 2010. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 107: 20768-20773.
21. Kimura, A., T. Naka, T. Nakahama, I. Chinen, K. Masuda, K. Nohara, Y. Fujii-Kuriyama, and T. Kishimoto. 2009. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J. Exp. Med. 206: 2027-2035.
22. N'Diaye, M., E. Le Ferrec, D. Lagadic-Gossmann, S. Corre, D. Gilot, V. Lecureur, P. Monteiro, C. Rauch, M. D. Galibert, and O. Fardel. 2006. Aryl hydrocarbon receptor-and calcium-dependent induction of the chemokine CCL1 by the environmental contaminant benzo[a]pyrene. J. Biol. Chem. 281: 19906-19915.
23. Lahoti, T. S., J. A. Boyer, A. Kusnadi, G. E. Muku, I. A. Murray, and G. H. Perdew. 2015. Aryl Hydrocarbon Receptor Activation Synergistically Induces Lipopolysaccharide-Mediated Expression of Proinflammatory Chemokine (c-c motif) Ligand 20. Toxicol. Sci. 148: 229-240.
24. Jux, B., S. Kadow, and C. Esser. 2009. Langerhans cell maturation and contact hypersensitivity are impaired in aryl hydrocarbon receptor-null mice. J. Immunol. 182: 6709-6717.
25. Platzer, B., S. Richter, D. Kneidinger, D. Waltenberger, M. Woisetschläger, and H. Strobl. 2009. Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells. J. Immunol. 183: 66-74.
26. van Grevenynghe, J., S. Rion, E. Le Ferrec, M. Le Vee, L. Amiot, R. Fauchet, and O. Fardel. 2003. Polycyclic aromatic hydrocarbons inhibit differentiation of human monocytes into macrophages. J. Immunol. 170: 2374-2381.
27. Cella, M., A. Fuchs, W. Vermi, F. Facchetti, K. Otero, J. K. Lennerz, J. M. Doherty, J. C. Mills, and M. Colonna. 2009. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722-725.
28. Hughes, T., B. Becknell, A. G. Freud, S. McClory, E. Briercheck, J. Yu, C. Mao, C. Giovenzana, G. Nuovo, L. Wei, et al. 2010. Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 32: 803-814.
29. Shin, J. H., L. Zhang, O. Murillo-Sauca, J. Kim, H. E. Kohrt, J. D. Bui, and J. B. Sunwoo. 2013. Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 110: 12391-12396.
30. Qiu, J., J. J. Heller, X. Guo, Z. M. Chen, K. Fish, Y. X. Fu, and L. Zhou. 2012. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36: 92-104.
31. Serafini, N., C. A. Vosshenrich, and J. P. Di Santo. 2015. Transcriptional regulation of innate lymphoid cell fate. Nat. Rev. Immunol. 15: 415-428.
32. Cella, M., and M. Colonna. 2015. Aryl hydrocarbon receptor: Linking environment to immunity. Semin. Immunol. 27: 310-314.
33. Song, J., M. Clagett-Dame, R. E. Peterson, M. E. Hahn, W. M. Westler, R. R. Sicinski, and H. F. DeLuca. 2002. A ligand for the aryl hydrocarbon receptor isolated from lung. Proc. Natl. Acad. Sci. USA 99: 14694-14699.
34. Mezrich, J. D., J. H. Fechner, X. Zhang, B. P. Johnson, W. J. Burlingham, and C. A. Bradfield. 2010. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185: 3190-3198.
35. Rannug, U., A. Rannug, U. Sjöberg, H. Li, R.Westerholm, and J. Bergman. 1995. Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem. Biol. 2: 841-845.
36. Duarte, J. H., P. Di Meglio, K. Hirota, H. Ahlfors, and B. Stockinger. 2013. Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo. PLoS One 8: e79819.
37. Wheeler, J. L., K. C. Martin, E. Resseguie, and B. P. Lawrence. 2014. Differential consequences of two distinct AhR ligands on innate and adaptive immune responses to influenza A virus. Toxicol. Sci. 137: 324-334.
38. Lee, Y. H., C. H. Lin, P. C. Hsu, Y. Y. Sun, Y. J. Huang, J. H. Zhuo, C. Y. Wang, Y. L. Gan, C. C. Hung, C. Y. Kuan, and F. S. Shie. 2015. Aryl hydrocarbon receptor mediates both proinflammatory and anti-inflammatory effects in lipopolysaccharide-activated microglia. Glia 63: 1138-1154.
39. Yeste, A., M. Nadeau, E. J. Burns, H. L. Weiner, and F. J. Quintana. 2012. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 109: 11270-11275.
40. Hayes, M. D., V. Ovcinnikovs, A. G. Smith, I. Kimber, and R. J. Dearman. 2014. The aryl hydrocarbon receptor: differential contribution to T helper 17 and T cytotoxic 17 cell development. PLoS One 9: e106955.
41. Borm, P. J., D. Robbins, S. Haubold, T. Kuhlbusch, H. Fissan, K. Donaldson, R. Schins, V. Stone, W. Kreyling, J. Lademann, et al. 2006. The potential risks of nanomaterials: a review carried out for ECETOC. Part. Fibre Toxicol. 3: 11.
42. Kendall, M., and S. Holgate. 2012. Health impact and toxicological effects of nanomaterials in the lung. Respirology 17: 743-758.
43. Mercer, R. R., J. F. Scabilloni, A. F. Hubbs, L. A. Battelli, W. McKinney, S. Friend, M. G. Wolfarth, M. Andrew, V. Castranova, and D. W. Porter. 2013. Distribution and fibrotic response following inhalation exposure to multi-walled carbon nanotubes. Part. Fibre Toxicol. 10: 33.
44. Landsiedel, R., U. G. Sauer, L. Ma-Hock, J. Schnekenburger, and M. Wiemann. 2014. Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies. Nanomedicine (Lond.) 9: 2557-2585.
45. Beamer, C. A., T. A. Girtsman, B. P. Seaver, K. J. Finsaas, C. T. Migliaccio, V. K. Perry, J. B. Rottman, D. E. Smith, and A. Holian. 2013. IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung. Nanotoxicology 7: 1070-1081.
46. Girtsman, T. A., C. A. Beamer, N. Wu, M. Buford, and A. Holian. 2014. IL-1R signalling is critical for regulation of multi-walled carbon nanotubes-induced acute lung inflammation in C57Bl/6 mice. Nanotoxicology 8: 17-27.
47. Maruyama, K., H. Haniu, N. Saito, Y. Matsuda, T. Tsukahara, S. Kobayashi, M. Tanaka, K. Aoki, S. Takanashi, M. Okamoto, and H. Kato. 2015. Endocytosis of Multiwalled Carbon Nanotubes in Bronchial Epithelial and Mesothelial Cells. BioMed Res. Int. 2015: 793186.
48. Shannahan, J. H., W. Bai, and J. M. Brown. 2015. Implications of scavenger receptors in the safe development of nanotherapeutics. Receptors Clin. Investig. 2: e811.
49. Hirano, S., S. Kanno, and A. Furuyama. 2008. Multi-walled carbon nanotubes injure the plasma membrane of macrophages. Toxicol. Appl. Pharmacol. 232: 244-251.
50. Hamilton, R. F., N. Wu, D. Porter, M. Buford, M. Wolfarth, and A. Holian. 2009. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part. Fibre Toxicol. 6: 35.
51. Nel, A., T. Xia, L. Mädler, and N. Li. 2006. Toxic potential of materials at the nanolevel. Science 311: 622-627.
52. Murphy, F. A., A. Schinwald, C. A. Poland, and K. Donaldson. 2012. The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells. Part. Fibre Toxicol. 9: 8.
53. Porter, D. W., A. F. Hubbs, B. T. Chen, W. McKinney, R. R. Mercer, M. G. Wolfarth, L. Battelli, N. Wu, K. Sriram, S. Leonard, et al. 2013. Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology 7: 1179-1194.
54. Palomäki, J., E. Välimäki, J. Sund, M. Vippola, P. A. Clausen, K. A. Jensen, K. Savolainen, S. Matikainen, and H. Alenius. 2011. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 5: 6861-6870.
55. Martinon, F., A. Mayor, and J. Tschopp. 2009. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27: 229-265.
56. Dostert, C., V. Pétrilli, R. Van Bruggen, C. Steele, B. T. Mossman, and J. Tschopp. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320: 674-677.
57. Haniu, H., N. Saito, Y. Matsuda, T. Tsukahara, K. Maruyama, Y. Usui, K. Aoki, S. Takanashi, S. Kobayashi, H. Nomura, et al. 2013. Culture medium type affects endocytosis of multi-walled carbon nanotubes in BEAS-2B cells and subsequent biological response. Toxicol. In Vitro 27: 1679-1685.
58. Wan, B., Z. X. Wang, Q. Y. Lv, P. X. Dong, L. X. Zhao, Y. Yang, and L. H. Guo. 2013. Single-walled carbon nanotubes and graphene oxides induce autophagosome accumulation and lysosome impairment in primarily cultured murine peritoneal macrophages. Toxicol. Lett. 221: 118-127.
59. Li, R., Z. Ji, H. Qin, X. Kang, B. Sun, M. Wang, C. H. Chang, X. Wang, H. Zhang, H. Zou, et al. 2014. Interference in autophagosome fusion by rare earth nanoparticles disrupts autophagic flux and regulation of an interleukin-1b producing inflammasome. ACS Nano 8: 10280-10292.
60. Seleverstov, O., O. Zabirnyk, M. Zscharnack, L. Bulavina, M. Nowicki, J. M. Heinrich, M. Yezhelyev, F. Emmrich, R. O'Regan, and A. Bader. 2006. Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation. Nano Lett. 6: 2826-2832.
61. Zhang, Y., F. Zheng, T. Yang, W. Zhou, Y. Liu, N. Man, L. Zhang, N. Jin, Q. Dou, Y. Zhang, et al. 2012. Tuning the autophagy-inducing activity of lanthanide-based nanocrystals through specific surface-coating peptides. Nat. Mater. 11: 817-826.
62. Wu, L., Y. Zhang, C. Zhang, X. Cui, S. Zhai, Y. Liu, C. Li, H. Zhu, G. Qu, G. Jiang, and B. Yan. 2014. Tuning cell autophagy by diversifying carbon nanotube surface chemistry. ACS Nano 8: 2087-2099.
63. Moghimi, S. M. 2002. Chemical camouflage of nanospheres with a poorly reactive surface: towards development of stealth and target-specific nanocarriers. Biochim. Biophys. Acta 1590: 131-139.
64. Ishida, T., X. Wang, T. Shimizu, K. Nawata, and H. Kiwada. 2007. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner. J. Control. Release 122: 349-355.
65. Wang, X., T. Ishida, and H. Kiwada. 2007. Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. J. Control. Release 119: 236-244.
66. Ishida, T., K. Atobe, X. Wang, and H. Kiwada. 2006. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicinencapsulation and high-dose first injection. J. Control. Release 115: 251-258.
67. Ishida, T., M. Ichihara, X. Wang, K. Yamamoto, J. Kimura, E. Majima, and H. Kiwada. 2006. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J. Control. Release 112: 15-25.
68. Ishida, T., and H. Kiwada. 2008. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. Int. J. Pharm. 354: 56-62.
69. Kalkanidis, M., G. A. Pietersz, S. D. Xiang, P. L. Mottram, B. Crimeen-Irwin, K. Ardipradja, and M. Plebanski. 2006. Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity. Methods 40: 20-29.
70. Yamada, M., M. Foote, and T. W. Prow. 2015. Therapeutic gold, silver, and platinum nanoparticles. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 7: 428-445.
71. Moon, J. J., B. Huang, and D. J. Irvine. 2012. Engineering nano-and microparticles to tune immunity. Adv. Mater. 24: 3724-3746.
72. Kodiha, M., Y. M. Wang, E. Hutter, D. Maysinger, and U. Stochaj. 2015. Off to the organelles-killing cancer cells with targeted gold nanoparticles. Theranostics 5: 357-370.
73. Khlebtsov, N., and L. Dykman. 2011. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem. Soc. Rev. 40: 1647-1671.
74. Almeida, J. P., A. L. Chen, A. Foster, and R. Drezek. 2011. In vivo biodistribution of nanoparticles. Nanomedicine (Lond.) 6: 815-835.
75. Lee, I. H., H. K. Kwon, S. An, D. Kim, S. Kim, M. K. Yu, J. H. Lee, T. S. Lee, S. H. Im, and S. Jon. 2012. Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo. Angew. Chem. Int. Ed. Engl. 51: 8800-8805.
76. Lin, A. Y., J. P. Almeida, A. Bear, N. Liu, L. Luo, A. E. Foster, and R. A. Drezek. 2013. Gold nanoparticle delivery of modified CpG stimulates macrophages and inhibits tumor growth for enhanced immunotherapy. PLoS One 8: e63550.
77. Massich, M. D., D. A. Giljohann, A. L. Schmucker, P. C. Patel, and C. A. Mirkin. 2010. Cellular response of polyvalent oligonucleotide-gold nanoparticle conjugates. ACS Nano 4: 5641-5646.
78. Arvizo, R., R. Bhattacharya, and P. Mukherjee. 2010. Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin. Drug Deliv. 7: 753-763.
79. Hirsch, L. R., R. J. Stafford, J. A. Bankson, S. R. Sershen, B. Rivera, R. E. Price, J. D. Hazle, N. J. Halas, and J. L. West. 2003. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl. Acad. Sci. USA 100: 13549-13554.
80. Huang, X., P. K. Jain, I. H. El-Sayed, and M. A. El-Sayed. 2007. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond.) 2: 681-693.
81. Liu, X., N. Huang, H. Li, Q. Jin, and J. Ji. 2013. Surface and size effects on cell interaction of gold nanoparticles with both phagocytic and nonphagocytic cells. Langmuir 29: 9138-9148.
82. França, A., P. Aggarwal, E. V. Barsov, S. V. Kozlov, M. A. Dobrovolskaia, and Á. González-Fernández. 2011. Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro. Nanomedicine (Lond.) 6: 1175-1188.
83. Yen, H. J., S. H. Hsu, and C. L. Tsai. 2009. Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 5: 1553-1561.
84. Sumbayev, V. V., I. M. Yasinska, C. P. Garcia, D. Gilliland, G. S. Lall, B. F. Gibbs, D. R. Bonsall, L. Varani, F. Rossi, and L. Calzolai. 2013. Gold nanoparticles downregulate interleukin-1b-induced pro-inflammatory responses. Small 9: 472-477.
85. Tsai, C. Y., S. L. Lu, C. W. Hu, C. S. Yeh, G. B. Lee, and H. Y. Lei. 2012. Sizedependent attenuation of TLR9 signaling by gold nanoparticles in macrophages. J. Immunol. 188: 68-76.
86. Moyano, D. F., M. Goldsmith, D. J. Solfiell, D. Landesman-Milo, O. R. Miranda, D. Peer, and V. M. Rotello. 2012. Nanoparticle hydrophobicity dictates immune response. J. Am. Chem. Soc. 134: 3965-3967.
87. Kim, E. Y., R. Schulz, P. Swantek, K. Kunstman, M. H. Malim, and S. M. Wolinsky. 2012. Gold nanoparticle-mediated gene delivery induces widespread changes in the expression of innate immunity genes. Gene Ther. 19: 347-353.
88. Sadauskas, E., G. Danscher, M. Stoltenberg, U. Vogel, A. Larsen, and H. Wallin. 2009. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine (Lond.) 5: 162-169.
89. Balasubramanian, S. K., J. Jittiwat, J. Manikandan, C. N. Ong, L. E. Yu, and W. Y. Ong. 2010. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials 31: 2034-2042.
90. Dietert, R. R. 2014. Developmental Immunotoxicity, Perinatal Programming, and Noncommunicable Diseases: Focus on Human Studies. Adv. Med. 2014: 867805.
91. Ahrenhoerster, L. S., E. R. Tate, P. A. Lakatos, X. Wang, and M. D. Laiosa. 2014. Developmental exposure to 2, 3, 7, 8 tetrachlorodibenzo-p-dioxin attenuates capacity of hematopoietic stem cells to undergo lymphocyte differentiation. Toxicol. Appl. Pharmacol. 277: 172-182.
92. Hogaboam, J. P., A. J. Moore, and B. P. Lawrence. 2008. The aryl hydrocarbon receptor affects distinct tissue compartments during ontogeny of the immune system. Toxicol. Sci. 102: 160-170.
93. Laiosa, M. D., and E. R. Tate. 2015. Fetal Hematopoietic Stem Cells Are the Canaries in the Coal Mine That Portend Later Life Immune Deficiency. Endocrinology 156: 3458-3465.
94. Winans, B., A. Nagari, M. Chae, C. M. Post, C. I. Ko, A. Puga, W. L. Kraus, and B. P. Lawrence. 2015. Linking the aryl hydrocarbon receptor with altered DNA methylation patterns and developmentally induced aberrant antiviral CD8+ T cell responses. J. Immunol. 194: 4446-4457.
95. Boule, L. A., C. G. Burke, B. M. Fenton, K. Thevenet-Morrison, T. A. Jusko, and B. P. Lawrence. 2015. Developmental activation of the AHR increases effector CD4+ T cells and exacerbates symptoms in autoimmune disease-prone Gnaq+/2 mice. Toxicol. Sci. 148: 555-566.
96. Boule, L. A., B. Winans, K. Lambert, B. A. Vorderstrasse, D. J. Topham, M. S. Pavelka, Jr., and B. P. Lawrence. 2015. Activation of the aryl hydrocarbon receptor during development enhances the pulmonary CD4+ T-cell response to viral infection. Am. J. Physiol. Lung Cell. Mol. Physiol. 309: L305-L313.
97. Boitano, A. E., J. Wang, R. Romeo, L. C. Bouchez, A. E. Parker, S. E. Sutton, J. R. Walker, C. A. Flaveny, G. H. Perdew, M. S. Denison, et al. 2010. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329: 1345-1348.
98. Singh, K. P., F. L. Casado, L. A. Opanashuk, and T. A. Gasiewicz. 2009. The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations. Biochem. Pharmacol. 77: 577-587.
99. Singh, K. P., R. W. Garrett, F. L. Casado, and T. A. Gasiewicz. 2011. Aryl hydrocarbon receptor-null allele mice have hematopoietic stem/progenitor cells with abnormal characteristics and functions. Stem Cells Dev. 20: 769-784.
100. Smith, B. W., S. S. Rozelle, A. Leung, J. Ubellacker, A. Parks, S. K. Nah, D. French, P. Gadue, S. Monti, D. H. Chui, et al. 2013. The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation. Blood 122: 376-385.
101. Fares, I., J. Chagraoui, Y. Gareau, S. Gingras, R. Ruel, N. Mayotte, E. Csaszar, D. J. Knapp, P. Miller, M. Ngom, et al. 2014. Cord blood expansion. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science 345: 1509-1512.
102. Holladay, S. D. 1999. Prenatal immunotoxicant exposure and postnatal autoimmune disease. Environ. Health Perspect. 107(Suppl. 5): 687-691.
103. Noakes, P. S., P. Taylor, S. Wilkinson, and S. L. Prescott. 2006. The relationship between persistent organic pollutants in maternal and neonatal tissues and immune responses to allergens: A novel exploratory study. Chemosphere 63: 1304-1311.
104. Sunyer, J., R. Garcia-Esteban, M. Alvarez, M. Guxens, F. Goñi, M. Basterrechea, M. Vrijheid, S. Guerra, and J. M. Antó. 2010. DDE in mothers' blood during pregnancy and lower respiratory tract infections in their infants. Epidemiology 21: 729-735.
105. Corsini, E., M. Sokooti, C. L. Galli, A. Moretto, and C. Colosio. 2013. Pesticide induced immunotoxicity in humans: a comprehensive review of the existing evidence. Toxicology 307: 123-135.
106. Ashley-Martin, J., A. R. Levy, T. E. Arbuckle, R. W. Platt, J. S. Marshall, and L. Dodds. 2015. Maternal exposure to metals and persistent pollutants and cord blood immune system biomarkers. Environ. Health 14: 52.
107. Leifer, C. A., and R. R. Dietert. 2011. Early life environment and developmental immunotoxicity in inflammatory dysfunction and disease. Toxicol. Environ. Chem. 93: 1463-1485.
108. Dietert, R. R., and M. S. Piepenbrink. 2006. Lead and immune function. Crit. Rev. Toxicol. 36: 359-385.
109. Gao, D., T. K. Mondal, and D. A. Lawrence. 2007. Lead effects on development and function of bone marrow-derived dendritic cells promote Th2 immune responses. Toxicol. Appl. Pharmacol. 222: 69-79.
110. Heo, Y., W. T. Lee, and D. A. Lawrence. 1998. Differential effects of lead and cAMP on development and activities of Th1-and Th2-lymphocytes. Toxicol. Sci. 43: 172-185.
111. Rogers, J. A., L. Metz, and V. W. Yong. 2013. Review: Endocrine disrupting chemicals and immune responses: a focus on bisphenol-A and its potential mechanisms. Mol. Immunol. 53: 421-430.
112. Roy, A., S. M. Bauer, and B. P. Lawrence. 2012. Developmental exposure to bisphenol A modulates innate but not adaptive immune responses to influenza A virus infection. PLoS One 7: e38448.
113. Menard, S., L. Guzylack-Piriou, M. Leveque, V. Braniste, C. Lencina, M. Naturel, L. Moussa, S. Sekkal, C. Harkat, E. Gaultier, et al. 2014. Food intolerance at adulthood after perinatal exposure to the endocrine disruptor bisphenol A. FASEB J. 28: 4893-4900.
114. Nakajima, Y., R. M. Goldblum, and T. Midoro-Horiuti. 2012. Fetal exposure to bisphenol A as a risk factor for the development of childhood asthma: an animal model study. Environ. Health 11: 8.
115. Khan, D., and S. A. Ahmed. 2015. Epigenetic Regulation of Non-Lymphoid Cells by Bisphenol A, a Model Endocrine Disrupter: Potential Implications for Immunoregulation. Front. Endocrinol. (Lausanne) 6: 91.
116. Boverhof, D. R., G. Ladics, B. Luebke, J. Botham, E. Corsini, E. Evans, D. Germolec, M. Holsapple, S. E. Loveless, H. Lu, et al. 2014. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary. Regul. Toxicol. Pharmacol. 68: 96-107.